Literature DB >> 14559209

Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G).

Hideyuki Aizawa1, Nives Zimmermann, Patricia E Carrigan, James J Lee, Marc E Rothenberg, Bruce S Bochner.   

Abstract

We recently identified a novel human sialic acid binding immunoglobulin-like lectin, Siglec-8, using mRNA from human eosinophils. To search for a mouse Siglec (mSiglec) ortholog of Siglec-8 and other mouse Siglec paralogs, we conducted public database searches with cDNA sequences of human Siglec-5 to -10 and identified two novel mSiglecs. One has significant sequence identity to human Siglec-5 and is a splice variant of mSiglec-F. The other has greatest sequence identity to human Siglec-10 (mSiglec-G). Both mSiglecs have extracellular Ig-like domains and intracellular tyrosine-based motifs. To determine whether these mSiglecs were relevant to mouse eosinophils, RT-PCR and Northern blot analysis were performed. We detected expression of mSiglec-5 (or -F), -10, and -E mRNA in purified mouse eosinophils, but Northern blot data comparing expression in tissues from normal, IL-5 transgenic, and allergen-sensitized and -challenged mice suggest that mSiglec-10 is probably most relevant to mouse eosinophils.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559209     DOI: 10.1016/s0888-7543(03)00171-x

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  21 in total

Review 1.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

2.  Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Kristin E Killoran; Helene F Rosenberg
Journal:  J Immunol Methods       Date:  2011-04-30       Impact factor: 2.303

Review 3.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

Review 4.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

5.  Temporal changes in myeloid cells in the cervix during pregnancy and parturition.

Authors:  Brenda C Timmons; Anna-Marie Fairhurst; Mala S Mahendroo
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry.

Authors:  Whitney W Stevens; Taeg S Kim; Lindsey M Pujanauski; Xueli Hao; Thomas J Braciale
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

Review 7.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Eosinophil survival and apoptosis in health and disease.

Authors:  Yong Mean Park; Bruce S Bochner
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

9.  Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13.

Authors:  Jae Youn Cho; Dae Jae Song; Alexa Pham; Peter Rosenthal; Marina Miller; Shanna Dayan; Taylor A Doherty; Ajit Varki; David H Broide
Journal:  Respir Res       Date:  2010-11-01

10.  Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.

Authors:  N Zimmermann; M L McBride; Y Yamada; S A Hudson; C Jones; K D Cromie; P R Crocker; M E Rothenberg; B S Bochner
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.